Center for Stem Cell and Translational Immunotherapy. Director: Khalid Shah, MS, PhD. Harvard Medical School.
Center for Stem Cell and Translational Immunotherapy. Director: Khalid Shah, MS, Ph.D. Harvard Medical School.

News

Videos & Audio

  • Dr. Khalid Shah Presents at the University of Toronto’s Centre of Pharmaceutical Oncology Seminar Series (University of Toronto 2025)
  • Using Gene-Edited Stem Cells and Oncolytic Viruses to Treat Lung Cancer Brain Metastases (JNCCN360 2025)
  • Un Enfoque Dual Para el Cáncer: Seguridad y Respuesta Inmunitaria Mejoradas con RIPK3 (Gaceta Médica 2025)

  • Revolutionary Dual Stem Cell Therapy Introduced for Combating Brain Metastasis in Non-Small Cell Lung Cancer Patients (Morning News 2025) (Bioengineer 2025)
  • New Dual Stem Cell Therapy Developed to Treat Brain Metastasis in Patients with Non Small Cell Lung Cancer (MedicalXPress 2025) (eCancer 2025)
  • New Dual Stem Therapy Developed to Treat Brain Metastasis in Patients with Non-Small Cell Lung Cancer (MGB Research Brief 2025)
  • Scientists Develop a Novel Safety Switch for Cancer Cell-Based Therapies (MGB Research Brief 2025)
  • Ioulia Vogiatzi awarded her PhD in Health Sciences focusing on Translational Cancer Research and Immunotherapy (Universiteit Gent 2024)
  • Dr. Khalid Shah discusses “Bench to Bedside” at BWH Grand Rounds (MGB Neurosurgery 2024)
  • Kendall Harrington MGB Intern Spotlight (MGB Neurosurgery 2024)
  • Aymane Kricha Awarded Fullbright Fellowship for his PhD Studies at CSTI (Fullbright Morocco 2024)
  • Exploring the Gut-Brain Connection: Uncovering its Mysteries (GEN 2024)
  • To Combat Cancer Treatment Resistance, Researchers Try Leveraging Evolution (National Cancer Institute 2024)
  • Gift Moves Brain Cancer Vaccine Toward Patient Trials (MGB Breakthroughs Because of You 2023)